Loading
What changed between revision 1 and revision 2, compared over the article's markdown source with its frontmatter — so a change to status, evidence or reversibility shows up as the edit it is.
Older · revision 1
Import· initial corpus import, not an edit
Initial import of content/wearable-health-sensors.md — the filesystem corpus, unchanged. Not an edit.
19.3 kB
Revision 1
Revision 2
lines 8–14 → 8–147 unchanged lines not shown
categories: ["longevity", "cybernetics"]categories: ["longevity", "cybernetics"]tags: ["wearables", "heart rhythm", "sleep", "screening", "consumer health", "measurement"]tags: ["wearables", "heart rhythm", "sleep", "screening", "consumer health", "measurement"]summary: "Consumer devices worn on the wrist or finger that continuously record pulse waveforms, movement, and skin temperature, and infer heart rhythm, sleep, and activity from them."summary: "Consumer devices worn on the wrist or finger that continuously record pulse waveforms, movement, and skin temperature, and infer heart rhythm, sleep, and activity from them."updated: "2026-07-27"updated: "2026-10-29"humanEvidence: "Prospective studies in hundreds of thousands of people show smartwatch algorithms can flag atrial fibrillation, and a randomized trial in older adults raised diagnosis rates; no trial has shown better clinical outcomes."humanEvidence: "Prospective studies in hundreds of thousands of people show smartwatch algorithms can flag atrial fibrillation, and a randomized trial in older adults raised diagnosis rates; no trial has shown better clinical outcomes."access: "Sold over the counter worldwide from roughly a hundred to several hundred dollars, some features behind subscriptions, several available only where a regulator has cleared them."access: "Sold over the counter worldwide from roughly a hundred to several hundred dollars, some features behind subscriptions, several available only where a regulator has cleared them."reversibility: "reversible"reversibility: "reversible"lines 69–83 → 69–8354 unchanged lines not shown
## Heart rhythm, the best-supported use## Heart rhythm, the best-supported use The Apple Heart Study enrolled roughly 419,000 US participants and monitored them for a median of about four months. Just over half a percent received an irregular pulse notification. Those who did were mailed an ECG patch, and among the minority who returned usable recordings, atrial fibrillation was present in about a third during the patch period.[^perez2019] Two readings of that fraction are both fair. It understates the algorithm, because atrial fibrillation is often paroxysmal and the patch arrived days after the alert. It also flatters the algorithm, because only notified participants were investigated, so the study could not estimate how many cases were missed.The Apple Heart Study enrolled roughly 419,000 US participants and monitored them for a median of about four months. Just over half a percent received an irregular pulse notification. Those who did were mailed an ECG patch, and among the minority who returned usable recordings, atrial fibrillation was present in about a third during the patch period.[^perez2019] The fraction can fairly be read in two directions. It understates the algorithm, because atrial fibrillation is often paroxysmal and the patch arrived days after the alert. It also flatters the algorithm, because only notified participants were investigated, so the study could not estimate how many cases were missed. The Fitbit Heart Study used a similar design in a comparable number of people and reported a much higher positive predictive value, defined against atrial fibrillation present during the window the algorithm had flagged rather than across a later monitoring period.[^lubitz2022] The two headline figures are not comparable, and the difference lies in the definition rather than in the hardware.The Fitbit Heart Study used a similar design in a comparable number of people and reported a much higher positive predictive value, defined against atrial fibrillation present during the window the algorithm had flagged rather than across a later monitoring period.[^lubitz2022] The two headline figures are therefore not comparable: they differ because of how a positive was defined, not because of the hardware. Clearances for rhythm features are narrow by design. Labelling restricts them to adults without a prior atrial fibrillation diagnosis and states that they are not a substitute for clinical evaluation; what the device produces is a prompt to seek one.Clearances for rhythm features are narrow by design. Labelling restricts them to adults without a prior atrial fibrillation diagnosis and states that they are not a substitute for clinical evaluation; what the device produces is a prompt to seek one. ## Sleep and breathing## Sleep and breathing Sleep tracking is heavily marketed and weakly validated. A comparison of seven consumer devices against polysomnography found that they estimated total sleep time reasonably well in healthy sleepers and classified sleep stages poorly, with performance varying by device and by stage.[^chinoy2021] The reason is structural. Polysomnography scores stages from EEG, eye movement, and muscle tone; a wrist device infers them from movement and cardiac features, and no wrist-accessible signal maps cleanly onto the stage definitions.Sleep tracking is heavily marketed and weakly validated. A comparison of seven consumer devices against polysomnography found that they estimated total sleep time reasonably well in healthy sleepers and classified sleep stages poorly, with performance varying by device and by stage.[^chinoy2021] The weakness has a structural cause. Polysomnography scores stages from EEG, eye movement, and muscle tone; a wrist device infers them from movement and cardiac features, and no wrist-accessible signal maps cleanly onto the stage definitions. A second failure mode matters more. Devices that infer sleep from stillness tend to score motionless wakefulness as sleep, so they overestimate sleep in precisely the people with insomnia who consult the data most closely. That also constrains how the epidemiology summarized under [[sleep-and-longevity]] can be translated into a nightly score.A second failure mode matters more. Devices that infer sleep from stillness tend to score motionless wakefulness as sleep, so they overestimate sleep in precisely the people with insomnia who consult the data most closely. That also constrains how the epidemiology summarized under [[sleep-and-longevity]] can be translated into a nightly score. lines 108–114 → 108–11424 unchanged lines not shown
Step counts are the oldest wearable metric and the one with the most epidemiology behind it. Pooled cohort data associate higher daily step counts with lower all-cause mortality, with the association flattening well below the familiar ten-thousand target, and at lower counts in older adults.[^paluch2022] These are observational findings and carry the obvious confound in both directions: illness reduces walking as well as following from it.Step counts are the oldest wearable metric and the one with the most epidemiology behind it. Pooled cohort data associate higher daily step counts with lower all-cause mortality, with the association flattening well below the familiar ten-thousand target, and at lower counts in older adults.[^paluch2022] These are observational findings and carry the obvious confound in both directions: illness reduces walking as well as following from it. Evidence that wearing a device changes behaviour durably is weaker than the market implies. In a randomized trial of a behavioural weight-loss programme in young adults, the group given a wearable activity monitor had lost less weight at two years than the group self-monitoring without one.[^jakicic2016] Nothing about that result argues against [[exercise-and-aging|physical activity]], which remains the best-supported intervention for the functional outcomes the longevity field cares about. It argues that measurement is not motivation.Evidence that wearing a device changes behaviour durably is weaker than the market implies. In a randomized trial of a behavioural weight-loss programme in young adults, the group given a wearable activity monitor had lost less weight at two years than the group self-monitoring without one.[^jakicic2016] Nothing about that result argues against [[exercise-and-aging|physical activity]], which remains the best-supported intervention for the functional outcomes the longevity field cares about. What it argues is that measuring activity is not the same as motivating it. Wearable streams increasingly feed other consumer health products: [[quantified-self]] tracking, [[biological-age]] estimates sold alongside [[epigenetic-clock|methylation tests]], the personalized models discussed under [[human-digital-twins]], and the [[dietary-supplements|supplement]] regimens of the [[biohacking]] community. Weight-management programmes built around [[glp-1-receptor-agonists]] have an obvious use for activity and lean-mass tracking, whose contribution to results has not been established. None of these composites has cleared the validation bar set out under [[aging-biomarkers]], and a watch-estimated maximal oxygen uptake is a model output rather than the treadmill measurement whose association with mortality gave the metric its reputation.Wearable streams increasingly feed other consumer health products: [[quantified-self]] tracking, [[biological-age]] estimates sold alongside [[epigenetic-clock|methylation tests]], the personalized models discussed under [[human-digital-twins]], and the [[dietary-supplements|supplement]] regimens of the [[biohacking]] community. Weight-management programmes built around [[glp-1-receptor-agonists]] have an obvious use for activity and lean-mass tracking, whose contribution to results has not been established. None of these composites has cleared the validation bar set out under [[aging-biomarkers]], and a watch-estimated maximal oxygen uptake is a model output rather than the treadmill measurement whose association with mortality gave the metric its reputation. lines 118–124 → 118–1243 unchanged lines not shown
Governance lags further. Health data from a consumer device sits largely outside medical privacy law in the United States, in the hands of advertising companies and insurers, and life insurers have offered premium discounts for sharing activity data. The concerns are those raised under [[genetic-discrimination]] and, for neural signals, under [[mental-privacy]] and [[neurorights]], transposed to a stream that is continuous, behavioural, and voluntarily surrendered. How voluntary it is depends on whether the device arrived through a purchase or through an employer or insurer programme, a distinction treated under [[quantified-self]]. The devices also cost money and reach the people least likely to need screening, which makes them a case for [[access-and-inequality]].Governance lags further. Health data from a consumer device sits largely outside medical privacy law in the United States, in the hands of advertising companies and insurers, and life insurers have offered premium discounts for sharing activity data. The concerns are those raised under [[genetic-discrimination]] and, for neural signals, under [[mental-privacy]] and [[neurorights]], transposed to a stream that is continuous, behavioural, and voluntarily surrendered. How voluntary it is depends on whether the device arrived through a purchase or through an employer or insurer programme, a distinction treated under [[quantified-self]]. The devices also cost money and reach the people least likely to need screening, which makes them a case for [[access-and-inequality]]. The contrast with implants clarifies what these devices are. A [[brain-computer-interface]] accepts surgical risk for signal quality that surface sensing cannot approach, and [[non-invasive-neuromodulation]] accepts weaker effects to avoid the surgery. Wearables sit at the far end of that trade, buying scale and reversibility at the cost of resolution. The open question is whether a low-resolution signal collected continuously from millions of people is worth more than a high-resolution signal collected from patients occasionally, and whether the diagnoses it produces amount to anything like the [[compression-of-morbidity]] the marketing invokes.Implants make a useful contrast. A [[brain-computer-interface]] accepts surgical risk for signal quality that surface sensing cannot approach, and [[non-invasive-neuromodulation]] accepts weaker effects to avoid the surgery. Wearables sit at the far end of that trade, buying scale and reversibility at the cost of resolution. The open question is whether a low-resolution signal collected continuously from millions of people is worth more than a high-resolution signal collected from patients occasionally, and whether the diagnoses it produces amount to anything like the [[compression-of-morbidity]] the marketing invokes. ## See also## See also removed, struck through added, underlinedLine numbers count the serialised markdown of each revision, frontmatter included.
140 lines are the same in both revisions, and 110 of them are not shown. Neither revision here is necessarily the current article — read Wearable health sensors for the text this wiki stands behind today.